Whiteside T L, Winkelstein A, Rabin B S
Cancer. 1977 Mar;39(3):1109-18. doi: 10.1002/1097-0142(197703)39:3<1109::aid-cncr2820390316>3.0.co;2-b.
Immunologic characterization of the neoplastic cells in the circulation of patients with CLL suggests these cells show significant differences in membrane characteristics from normal B lymphocytes. Although the leukemic cells bear a homogenous membrane-associated immunoglobulin, they also react with an anti-human T cell serum. In all patients studied, 60-90% of the cells, were stained by this antiserum. This suggests that the leukemic cells share antigenic determinants with T lymphocytes. CLL cells, unlike normal B cells, showed a marked increase in mouse-complement receptors. No increase in receptors for guinea pig complement was observed in the leukemic cells. The population of SIg-bearing lymphocytes was significantly greater than that of complement-receptor bearing lymphocytes. The total number of E-rosetting cells was increased in all CLL patients. Mitogenic responses of the leukemic cells were depressed and delayed. These results suggest that neoplastic lymphocytes cannot be classified as T- or B-derived on the basis of criteria used to define normal lymphocytes.
慢性淋巴细胞白血病(CLL)患者循环系统中肿瘤细胞的免疫学特征表明,这些细胞在膜特性方面与正常B淋巴细胞存在显著差异。尽管白血病细胞带有同质的膜相关免疫球蛋白,但它们也能与抗人T细胞血清发生反应。在所有研究的患者中,60% - 90%的细胞被这种抗血清染色。这表明白血病细胞与T淋巴细胞共享抗原决定簇。与正常B细胞不同,CLL细胞的小鼠补体受体显著增加。在白血病细胞中未观察到豚鼠补体受体的增加。带有表面免疫球蛋白(SIg)的淋巴细胞群体明显大于带有补体受体的淋巴细胞群体。所有CLL患者中E花环形成细胞的总数均增加。白血病细胞的有丝分裂反应受到抑制且延迟。这些结果表明,根据用于定义正常淋巴细胞的标准,肿瘤淋巴细胞不能被归类为T细胞或B细胞来源。